Paromomycin

Back to search

Molecule Structure

Scientific Name

Paromomycin

Description of the Drug

Paromomycin is an aminoglycoside antibiotic used in the treatment of acute and chronic intestinal amebiasis, and as an adjunct for the management of hepatic coma.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01421

Brand Name(s)

Not Available

Company Owner(s)

Parke Davis Div Warner Lambert Co, Sun Pharmaceutical Industries Inc, Parkedale Pharmaceuticals Inc, King Pharmaceuticals Inc Sub Pfizer Inc, Heritage Pharmaceuticals Inc Dba Avet Pharmaceuticals Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Bacterial 70S ribosome PROTEIN NUCLEIC-ACID COMPLEX INHIBITOR CHEMBL2363135

Unichem Links

SureChEMBL SCHEMBL4072
PharmGKB PA164784023
Human Metabolome Database HMDB0015490
DrugBank DB01421
PubChem: Thomson Pharma 24380735
PubChem 165580
Mcule MCULE-1528618434
NMRShiftDB 70114032
Nikkaji J8.952D
PDBe PAR
BindingDB 50240054
EPA CompTox Dashboard DTXSID8023424
DrugCentral 2067
Brenda 210630 2215
ChemicalBook CB6911922
rxnorm PAROMOMYCIN PAROMOMYCIN SULFATE
KEGG Ligand C00832
ChEBI 7934
ZINC ZINC000060183170